Impact of endobronchial valves on patient reported outcomes in severe emphysema

M. Dransfield (Birmingham, United States of America), S. Bhatt (Birmingham, United States of America), D. Slebos (Groningen, Netherlands), K. Klooster (Groningen, Netherlands), F. Sciurba (Pittsburgh, United States of America), P. Shah (London, United Kingdom), J. Garner (London, United Kingdom), S. Radhakrishnan (Redwood City, United States of America), N. Shargill (Redwood City, United States of America), N. Marchetti (Philadelphia, United States of America), G. Criner (Philadelphia, United States of America)

Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Session: ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Session type: Clinical trials session
Number: 447
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Dransfield (Birmingham, United States of America), S. Bhatt (Birmingham, United States of America), D. Slebos (Groningen, Netherlands), K. Klooster (Groningen, Netherlands), F. Sciurba (Pittsburgh, United States of America), P. Shah (London, United Kingdom), J. Garner (London, United Kingdom), S. Radhakrishnan (Redwood City, United States of America), N. Shargill (Redwood City, United States of America), N. Marchetti (Philadelphia, United States of America), G. Criner (Philadelphia, United States of America). Impact of endobronchial valves on patient reported outcomes in severe emphysema. 447

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of pneumothorax as complication of endobronchial valve treatment on patient-reported outcomes
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021


Predictors of clinical outcome in emphysema patients with atelectasis following endoscopic valve therapy
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015

Endobronchial valve placement impact on breathing pattern during exercise in patients with severe emphysema
Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases
Year: 2019




Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment
Source: Eur Respir J 2013; 41: 302-308
Year: 2013



Endobronchial valves for severe emphysema
Source: Eur Respir Rev, 28 (152) 180121; 10.1183/16000617.0121-2018
Year: 2019



Factors associated with good response in a cohort of patients with severe emphysema and complete inter-lobar fissures undergoing endo-bronchial valve insertion
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015


Development of endoscopic valve therapy in patients with severe emphysema
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015

One year follow-up after endobronchial valve treatment in patients with emphysema without interlobar collateral ventilation
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016


Impairment of pulmonary function as a main risk factor for ineffective endobronchial valve placement in patients with chronic cavitary tuberculosis
Source: Virtual Congress 2020 – Conventional bronchoscopy
Year: 2020


The sequentional intrabronchial valve implantation as the treatment option for severe heterogeneous emphysema
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016


Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism
Source: Eur Respir J, 49 (5) 1601980; 10.1183/13993003.01980-2016
Year: 2017




Twelve-month positive outcomes of Zephyr endobronchial valves in severe emphysema patients:  LIBERATE trial
Source: International Congress 2018 – Interventional pulmonology highlights in 2018: ELVR, TLD and BT
Year: 2018



Survival after endoscopic valve therapy in patients with severe emphysema
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016

Pulmonary function before and early after endobronchial valve placement in patients with chronic cavitary tuberculosis
Source: International Congress 2019 – Interventional pulmonology: re-sculpting the airway
Year: 2019

Endobronchial valve treatment versus standard medical care in patients with emphysema without interlobar collateral ventilation
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015

Impact of endoscopic valve therapy on hypercapnia in patients with chronic hypercapnic failure based on a severe lung emphysema
Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology
Year: 2020




Endobronchial valves for emphysema treatment: how do I do it and in which patients?
Source: Annual Congress 2012 - PG1 Interventional pulmonology procedures: best practice
Year: 2012

Endobronchial microbiological colonisation in stable COPD patients with severe emphysema undergoing endoscopic lung volume reduction.
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017

Unilateral bronchoscopic volume reduction with valve implants in patients with severe emphysema
Source: Eur Respir J 2003; 22: Suppl. 45, 206s
Year: 2003

Endobronchial valve treatment of terminal emphysema patients with high heterogeneity score
Source: Annual Congress 2010 - New toys, old problems: extrapleural lung volume reduction, sedation and comfort in bronchoscopy
Year: 2010